P.1.36 Caffeine exacerbates MDMA “Ecstasy”-induced hyperthermia: a role for dopamine D1 receptors

N. Vanattou-Saifoudine , R. McNamara , A. Harkin
European Neuropsychopharmacology 18

2008
34
2012
Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats.

N Vanattou-Saïfoudine , R McNamara , A Harkin
British Journal of Pharmacology 160 ( 4) 860 -877

35
2010
CAFFEINE PROMOTES MDMA" ECSTASY"-INDUCED DOPAMINE RELEASE IN STRIATAL AND HYPOTHALAMIC TISSUE SLICES; A ROLE FOR ADENOSINE A (1) RECEPTORS

N Vanattou Saifoudine , A Gossen , A Harkin
IRISH JOURNAL OF MEDICAL SCIENCE 179 S143 -S143

2010
Proteomic technologies for biomarker studies in psychiatry: advances and needs.

Daniel Martins-de-Souza , Paul C. Guest , Natacha Vanattou-Saifoudine , Laura W. Harris
International Review of Neurobiology 101 65 -94

26
2011
Abnormalities in metabolism and hypothalamic-pituitary-adrenal axis function in schizophrenia.

Paul C. Guest , Daniel Martins-de-Souza , Natacha Vanattou-Saifoudine , Laura W. Harris
International Review of Neurobiology 101 145 -168

23
2011
Clenbuterol activates the central IL-1 system via the β2-adrenoceptor without provoking inflammatory response related behaviours in rats.

Karen M. Ryan , Éadaoin W. Griffin , Katie J. Ryan , Riffat Tanveer
Brain Behavior and Immunity 56 114 -129

7
2016
Metabolic, hormonal and stress-related molecular changes in post-mortem pituitary glands from schizophrenia subjects

Divya Krishnamurthy , Laura W. Harris , Yishai Levin , Theodoros A. Koutroukides
World Journal of Biological Psychiatry 14 ( 7) 478 -489

44
2013
Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function

Daniel Martins-de-Souza , Paul C. Guest , Natacha Vanattou-Saifoudine , Hassan Rahmoune
European Archives of Psychiatry and Clinical Neuroscience 262 ( 8) 657 -666

56
2012
A role for adenosine A1 receptor blockade in the ability of caffeine to promote MDMA Ecstasy -induced striatal dopamine release

Natacha Vanattou-Saïfoudine , Anna Gossen , Andrew Harkin , Neuropsychopharmacology Research Group
European Journal of Pharmacology 650 ( 1) 220 -228

16
2011
Dopamine D1 receptor-mediated intracellular responses in the hypothalamus after co-administration of caffeine with MDMA.

Natacha Vanattou-Saïfoudine , Brendan Behan , Andrew Harkin
Basic & Clinical Pharmacology & Toxicology 110 ( 3) 283 -289

6
2012
Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy').

Natacha Vanattou-Saïfoudine , Ruth McNamara , Andrew Harkin
Psychopharmacology 211 ( 1) 15 -25

18
2010
A robust model of Stimulus-Specific Adaptation validated on neuromorphic hardware

Natacha Vanattou-Saïfoudine , Chao Han , Renate Krause , Eleni Vasilaki
Scientific Reports 11 ( 1) 17904 -17904

3
2021
Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients

D Martins-de-Souza , P C Guest , L W Harris , N Vanattou-Saifoudine
Translational Psychiatry 2 ( 3)

125
2012
MECHANISMS UNDERLYING THE ABILITY OF CAFFEINE TO EXACERBATE THE ACUTE TOXICITY OF MDMA (" ECSTASY'')

N Vanattou-Saifoudine , R McNamara , A Harkin
IRISH JOURNAL OF MEDICAL SCIENCE 179 S286 -S286

2010